Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
-
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

2 Years 2 Months

13 Years 5 Months

Fund AUM

₹533 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹500
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.69%

0.91%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

57

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.85%)
  2. J.B. Chemicals & Pharmaceuticals Ltd(9.44%)
  3. Max Healthcare Institute Ltd Ordinary Shares(5.88%)
  4. Fortis Healthcare Ltd(5.54%)
  5. Lupin Ltd(5.29%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(92.44%)
  2. Basic Materials(7.56%)

Health

(100%)

Equity %

98.7%

99.7%

Debt %

-

-

P/E

42.19

35.73

P/B

7.37

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-1.67%

-2.91%

3-Month Return

-0.51%

-1.77%

6-Month Return

0.17%

-1.1%

1-Year Return

8.01%

3.24%

3-Year Return

-

24.53%

5-Year Return

-

16.64%

Sharpe

-

1.17

Alpha

-

0.22

Beta

-

0.9

Standard Deviation

-

15.21

Information Ratio

-

-0.47

Description

WhiteOak Capital Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Trupti Agrawal, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Ramesh Mantri

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons